- Home
- Publications
- Publication Search
- Publication Details
Title
Current and future biomarkers for pancreatic adenocarcinoma
Authors
Keywords
-
Journal
TUMOR BIOLOGY
Volume 39, Issue 6, Pages 101042831769223
Publisher
SAGE Publications
Online
2017-06-16
DOI
10.1177/1010428317692231
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic and predictive markers in pancreatic adenocarcinoma
- (2016) Nha Le et al. DIGESTIVE AND LIVER DISEASE
- Pancreatic cancer
- (2016) Terumi Kamisawa et al. LANCET
- Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma Undergoing Gemcitabine-Based Chemoradiotherapy
- (2016) Reiko Yamada et al. PANCREAS
- Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma
- (2016) Hyung Soon Park et al. Cancer Research and Treatment
- MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions
- (2016) Yasmin G Hernandez World Journal of Gastrointestinal Oncology
- Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis
- (2016) Wei Han et al. PLoS One
- Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer
- (2015) Mahito Miyamae et al. BRITISH JOURNAL OF CANCER
- Detection ofK-rasgene mutation by liquid biopsy in patients with pancreatic cancer
- (2015) Hideaki Kinugasa et al. CANCER
- High Levels of Cell-Free Circulating Nucleic Acids in Pancreatic Cancer are Associated With Vascular Encasement, Metastasis and Poor Survival
- (2015) Nidhi Singh et al. CANCER INVESTIGATION
- SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial
- (2015) M. Hidalgo et al. CLINICAL CANCER RESEARCH
- microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis
- (2015) Adam E. Frampton et al. EUROPEAN JOURNAL OF CANCER
- Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer
- (2015) Y.B. Ma et al. GENETICS AND MOLECULAR RESEARCH
- Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis
- (2015) B.-S. Li et al. GENETICS AND MOLECULAR RESEARCH
- A prognostic index model to predict the clinical outcomes for advanced pancreatic cancer patients following palliative chemotherapy
- (2015) Peng Xue et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancer
- (2015) C. Jenkinson et al. Journal of Proteomics
- Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma
- (2015) Michela Capello et al. JNCI-Journal of the National Cancer Institute
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- Evaluation of circulating ADH and MIC-1 as diagnostic markers in Egyptian patients with pancreatic cancer
- (2015) Amal A. Mohamed et al. PANCREATOLOGY
- Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis
- (2015) Si-Biao Su WORLD JOURNAL OF GASTROENTEROLOGY
- Circulating RNAs as new biomarkers for detecting pancreatic cancer
- (2015) Takahiro Kishikawa WORLD JOURNAL OF GASTROENTEROLOGY
- Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: A promising biomarker and therapeutic target for pancreatic cancer
- (2015) Donglin Liu et al. Oncotarget
- Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma
- (2015) Michela Capello et al. JNCI-Journal of the National Cancer Institute
- Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer
- (2015) Renata D'Alpino Peixoto et al. Cancer Medicine
- Gene Expression Levels as Predictive Markers of Outcome in Pancreatic Cancer after Gemcitabine-Based Adjuvant Chemotherapy
- (2015) Hayato Fujita et al. NEOPLASIA
- A Pilot Study to Develop a Diagnostic Test for Pancreatic Ductal Adenocarcinoma Based on Differential Expression of Select miRNA in Plasma and Bile
- (2014) Gregory A Cote et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma
- (2014) Xiaobing Wang et al. BMC CANCER
- Diagnostic Performance of Serum Macrophage Inhibitory Cytokine-1 in Pancreatic Cancer: A Meta-Analysis and Meta-Regression Analysis
- (2014) Yan-Zhi Chen et al. DNA AND CELL BIOLOGY
- Diagnostic Significance of Serum Osteopontin Level for Pancreatic Cancer: A Meta-Analysis
- (2014) Jian-Jun Li et al. Genetic Testing and Molecular Biomarkers
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients
- (2014) Neil Desai et al. Translational Oncology
- Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer
- (2014) Allen S. Ho et al. Translational Oncology
- MicroRNA-196a and -196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer
- (2014) Emily P. Slater et al. Translational Oncology
- Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer
- (2014) Jin Wang et al. Journal of Cancer
- MicroRNA expression profiling of diagnostic needle aspirates from surgical pancreatic cancer specimens
- (2014) Tae Ho Hong et al. Annals of Surgical Treatment and Research
- Circulating U2 Small Nuclear RNA Fragments as a Novel Diagnostic Tool for Patients with Epithelial Ovarian Cancer
- (2013) J. D. Kuhlmann et al. CLINICAL CHEMISTRY
- Detection of Circulating Pancreas Epithelial Cells in Patients With Pancreatic Cystic Lesions
- (2013) Andrew D. Rhim et al. GASTROENTEROLOGY
- The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies
- (2013) Lorenzo Fuccio et al. GASTROINTESTINAL ENDOSCOPY
- Long Noncoding RNAs: Past, Present, and Future
- (2013) J. T. Y. Kung et al. GENETICS
- Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial
- (2013) William Greenhalf et al. JNCI-Journal of the National Cancer Institute
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum Osteopontin and Tissue Inhibitor of Metalloproteinase 1 as Diagnostic and Prognostic Biomarkers for Pancreatic Adenocarcinoma
- (2013) Katherine E. Poruk et al. PANCREAS
- Aberrant Expression miR-196a Is Associated With Abnormal Apoptosis, Invasion, and Proliferation of Pancreatic Cancer Cells
- (2013) Minghao Liu et al. PANCREAS
- Alternative Processing of the U2 Small Nuclear RNA Produces a 19–22nt Fragment with Relevance for the Detection of Non-Small Cell Lung Cancer in Human Serum
- (2013) Julien Mazières et al. PLoS One
- Potentials of Plasma NGAL and MIC-1 as Biomarker(s) in the Diagnosis of Lethal Pancreatic Cancer
- (2013) Sukhwinder Kaur et al. PLoS One
- MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm
- (2013) Yue Xue et al. Cancer Genetics
- The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms
- (2012) S. Caponi et al. ANNALS OF ONCOLOGY
- PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma
- (2012) David V. Gold et al. CANCER
- Pathology and Molecular Genetics of Pancreatic Neoplasms
- (2012) Laura D. Wood et al. CANCER JOURNAL
- EMT and Dissemination Precede Pancreatic Tumor Formation
- (2012) Andrew D. Rhim et al. CELL
- Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma
- (2012) Alexander Baraniskin et al. INTERNATIONAL JOURNAL OF CANCER
- Analyzing S100A6 Expression in Endoscopic Ultrasonography-guided Fine-needle Aspiration Specimens
- (2012) Guo Zihao et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial
- (2012) Sophie Gourgou-Bourgade et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma
- (2012) Nicolai A Schultz et al. MODERN PATHOLOGY
- Feasibility of Fecal MicroRNAs as Novel Biomarkers for Pancreatic Cancer
- (2012) Alexander Link et al. PLoS One
- Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers
- (2011) Long Cui et al. CLINICAL BIOCHEMISTRY
- Serum Biomarker Panels for the Detection of Pancreatic Cancer
- (2011) R. E. Brand et al. CLINICAL CANCER RESEARCH
- Serum MicroRNA Expression Profile as a Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer
- (2011) R. Liu et al. CLINICAL CHEMISTRY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aberrant Overexpression of Satellite Repeats in Pancreatic and Other Epithelial Cancers
- (2011) D. T. Ting et al. SCIENCE
- MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
- (2010) Nils Habbe et al. CANCER BIOLOGY & THERAPY
- Osteopontin but not osteonectin favors the metastatic growth of pancreatic cancer cell lines
- (2010) Maria Zhivkova-Galunska et al. CANCER BIOLOGY & THERAPY
- MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions
- (2010) M. C. du Rieu et al. CLINICAL CHEMISTRY
- Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview
- (2010) S. Bünger et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Soluble iC3b as an Early Marker for Pancreatic Adenocarcinoma Is Superior to CA19.9 and Radiology
- (2010) Angela Märten et al. JOURNAL OF IMMUNOTHERAPY
- Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer
- (2010) Jipei Liao et al. Molecular Cancer
- Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer
- (2010) M. C. Villarroel et al. MOLECULAR CANCER THERAPEUTICS
- Aberrant MicroRNA-155 Expression Is an Early Event in the Multistep Progression of Pancreatic Adenocarcinoma
- (2010) Ji Kon Ryu et al. PANCREATOLOGY
- MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease
- (2009) J. Wang et al. Cancer Prevention Research
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma
- (2009) R. Marechal et al. CLINICAL CANCER RESEARCH
- Survival and Prognostic Factors of Unresectable Pancreatic Cancer
- (2009) Joo Kyung Park et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Modelling prognostic factors in advanced pancreatic cancer
- (2008) D D Stocken et al. BRITISH JOURNAL OF CANCER
- Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
- (2008) James J. Farrell et al. GASTROENTEROLOGY
- MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival
- (2008) Mary Dillhoff et al. JOURNAL OF GASTROINTESTINAL SURGERY
- MicroRNAs accurately identify cancer tissue origin
- (2008) Nitzan Rosenfeld et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search